Effective prison-based treatment and linkage to care after release.

Lancet Infect Dis

Department of Gastroenterology, St Vincent's Hospital and the University of Melbourne, Fitzroy, VIC 3065, Australia. Electronic address:

Published: November 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(19)30536-5DOI Listing

Publication Analysis

Top Keywords

effective prison-based
4
prison-based treatment
4
treatment linkage
4
linkage care
4
care release
4
effective
1
treatment
1
linkage
1
care
1
release
1

Similar Publications

Background: Extended-release naltrexone (XR-NTX, Vivitrol) is an effective, but underutilized, evidence-based treatment for people with opioid use disorder (POUD) who are incarcerated. Networks of family, friends, and clinicians serve as social influencers of health behaviors, including XR-NTX initiation, and are especially salient in Appalachia.

Objectives: Using a triangulation of perspectives, this study examined concordance between the social network themes that emerged from qualitative interviews with clinicians and POUD social network findings.

View Article and Find Full Text PDF

Preliminary evidence that self-incentives uniquely promote smoking cessation in incarcerated populations: A pilot randomized controlled trial.

J Subst Use Addict Treat

December 2024

The University of Manchester, Manchester Centre for Health Psychology, Division of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester, UK; Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Introduction: Smoking prevalence rates in prison are typically four times higher than the rates found within community-based settings, increasing premature mortality. Encouraging smokers to self-administer incentives contingent on abstinence (i.e.

View Article and Find Full Text PDF

Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons.

Lancet Public Health

January 2025

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA; Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, Yale University, New Haven, CT, USA.

The 1990 resolution by the UN General Assembly committed member states to provide health-care equity for people in prison, who are included in the global goals to control HIV and eliminate hepatitis C virus (HCV) by 2030. WHO has set ambitious HCV elimination targets by including people who inject drugs (PWID), yet has not prioritised PWID who are incarcerated, a substantial population who have or are at risk for HCV infection. Human rights principles of health-care equity stipulate that "prisoners should enjoy the same standards of health care that are available in the community, without discrimination on the grounds of their legal status".

View Article and Find Full Text PDF
Article Synopsis
  • * A study found that dogs participating in a DTP showed significant improvements in various training tasks, with many dogs displaying more positive behaviors and fewer negative ones after the program.
  • * While not all negative behaviors were eliminated, the DTP seemed to promote the dogs' welfare and increase the possibility of successful rehoming, while also giving incarcerated individuals a chance to contribute positively to their community.
View Article and Find Full Text PDF

The prison-based Therapeutic Community: Resident recommendations for program improvement.

J Subst Use Addict Treat

August 2024

College of Criminology & Criminal Justice, Florida State University, Tallahassee, USA. Electronic address:

Introduction: The prison-based Therapeutic Community (TC) is widely used within correctional institutions to address substance use disorders (SUDs). While most evaluations of the prison-based TC find the program to be effective, recent mixed evidence and the continued surge of the opioid crisis call for deeper investigation into program operations, barriers to engagement, and sources of treatment effect heterogeneity. Notably lacking from prior evaluations, and critical to our understanding of variable program engagement, is first-hand experiences and perceptions from program participants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!